Natco Pharma has declared an interim dividend of ₹2 per equity share (face value ₹2 each), translating to a 100% payout for the financial year 2025-26.
The company has set Tuesday, August 19, 2025, as the record date to determine the list of shareholders eligible for the dividend. Those holding shares of Natco Pharma on this date will be entitled to receive the payout.
As per the company’s announcement, the distribution of the interim dividend will commence from August 26, 2025. This move underscores Natco Pharma’s consistent commitment to rewarding its investors while maintaining strong financial performance.
NATCO Pharma Q1 Results
NATCO Pharma has announced its financial results for the first quarter ended June 30, 2025, showing largely stable revenue but a sharp drop in profitability compared to last year.
The company posted a consolidated total revenue of ₹1,390.6 crore in Q1 FY26, a marginal 1.42% decline from ₹1,410.7 crore in the same quarter of the previous fiscal. Despite the flat revenue trend, operating performance remained strong, with EBITDA coming in at ₹632.7 crore, translating to robust margins of 45.5%.
However, profitability took a significant hit. Consolidated net profit fell to ₹480.3 crore, down 28.1% from ₹668 crore in Q1 FY25.
